장시간 작용형 약물전달 기술 및 서비스 시장 : 부문별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Long-Acting Drug Delivery Technologies and Services Market size was valued at USD 12,234.23 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Long-Acting Drug Delivery Technologies and Services imply advanced methods and systems designed to administer medications over extended periods with fewer doses compared to traditional methods. These technologies aim to improve patient adherence, enhance therapeutic efficacy, and reduce the frequency of administration.

Long-Acting Drug Delivery Technologies and Services Market- Market Dynamics

Increasing patient adherence and the prevalence of hypertension, and psychiatric diseases are expected to propel market demand

Diabetes, hypertension, cancer, and psychiatric disorders are increasingly common and often require long-term management. Long-acting formulations reduce the frequency of dosing and improve patient adherence which is expected to bolster market growth. There is a growing emphasis on preventive healthcare, which includes using long-acting medications to manage conditions before they become severe, thereby improving quality of life and reducing long-term healthcare costs.

The development of long-acting formulations for biologics and biosimilars is expanding the market. These drugs often require complex delivery systems to maintain stability and effectiveness over time. Innovations in pharmaceutical technology, such as nano-based drug delivery systems, advanced polymers, and improved formulation techniques, are making long-acting drug delivery systems more effective and versatile. Enhanced convenience from fewer doses and less frequent administration encourages patients to stick to their treatment plans, which can lead to better health outcomes and reduced healthcare costs. All these benefits are projected to contribute to market growth.

Long-Acting Drug Delivery Technologies and Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Material segmentation, the polymer-based segment was predicted to show maximum market share in the year 2023, owing to its high efficiency in long-acting drug delivery.

Based on Dosage Form segmentation, long acting injectables segment was the leading Dosage Form in 2023, owing to its greater effects in drug delivery & quick response.

Based on End User segmentation, the pharmaceutical & biotech companies' segment was the leading End User segment in 2023, owing to the high demand for drugs in the pharma & biotech industries.

Based on region, North America was the leading revenue generator in 2023, due to the government & FDA support.

Long-Acting Drug Delivery Technologies and Services Market- Segmentation Analysis:

The Global Long-Acting Drug Delivery Technologies and Services Market is segmented based on Material, Dosage Form, End User, and Region.

The market is divided into two categories based on Material: polymer-based and non-polymer based. The polymer-based segment dominates the market. Polymer-based drugs provide long-acting durability and thus are gaining more traction in the market.

The market is divided into four categories based on Dosage Form: long acting injectables, acting implantables, long-acting oral, and others. The long acting injectables segment dominates the market. Injectables have high efficiency in common respiratory disorders which is fueling segment growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research & development, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing number of drug development and pharma technologies are boosting market demand.

Long-Acting Drug Delivery Technologies and Services Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The United States holds a significant share of the global market due to advanced healthcare infrastructure, high adoption rates of new technologies, and substantial R&D investments. Europe is a major market with a growing emphasis on personalized medicine and advanced drug delivery systems. Key markets include Germany, France, and the UK. Latin America is an emerging market with expanding healthcare access and increasing investments in healthcare infrastructure.

Long-Acting Drug Delivery Technologies and Services Market- Competitive Landscape:

The long-acting drug delivery technologies and services market is characterized by significant competition and ongoing innovations. Companies in this space are engaged in various strategies, including technological advancements, partnerships, collaboration, and market expansions. Companies are investing in nanotechnology, biodegradable polymers, and advanced microsphere technologies to enhance long-acting drug delivery systems. Strategic partnerships between pharmaceutical companies, technology firms, and academic institutions are crucial for advancing long-acting drug delivery technologies and expanding market reach.

Recent Developments:

In February 2023, EyePoint Pharmaceuticals and Rallybio formed a research agreement to assess Rallybio's inhibitors of complement component 5 (C5) using Durasert(R) technology.

In April 2023, the U.S. FDA approved ABILIFY ASIMTUFII, a long-acting injectable suspension, developed by Otsuka, administered intramuscularly once every two months for the treatment of schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET KEY PLAYERS

• Pfizer Inc.
• Roche Holding AG
• Novartis International AG
• Johnson & Johnson
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Viatris Inc.
• ALZA Corporation
• Eli Lilly and Company
• Merck & Co., Inc.
• Sanofi S.A.
• AbbVie Inc.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• AstraZeneca plc
• Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY MATERIAL- MARKET ANALYSIS, 2019-2032

• Polymer-based
• Non-polymer Based

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019-2032

• Long Acting Injectables
• Long Acting Implantable
• Long-acting Oral
• Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

• Pharmaceutical & Biotech Companies
• Research & Development
• Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Long-Acting Drug Delivery Technologies and Services Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Long-Acting Drug Delivery Technologies and Services Market Snippet by Material
  • 2.1.2. Long-Acting Drug Delivery Technologies and Services Market Snippet by Dosage Form
  • 2.1.3. Long-Acting Drug Delivery Technologies and Services Market Snippet by End User
  • 2.1.4. Long-Acting Drug Delivery Technologies and Services Market Snippet by Country
  • 2.1.5. Long-Acting Drug Delivery Technologies and Services Market Snippet by Region
• 2.2. Competitive Insights

3. Long-Acting Drug Delivery Technologies and Services Key Market Trends

• 3.1. Long-Acting Drug Delivery Technologies and Services Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Long-Acting Drug Delivery Technologies and Services Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Long-Acting Drug Delivery Technologies and Services Market Opportunities
• 3.4. Long-Acting Drug Delivery Technologies and Services Market Future Trends

4. Long-Acting Drug Delivery Technologies and Services Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Long-Acting Drug Delivery Technologies and Services Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Long-Acting Drug Delivery Technologies and Services Market Landscape

• 6.1. Long-Acting Drug Delivery Technologies and Services Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Long-Acting Drug Delivery Technologies and Services Market - By Material

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Material, 2024 & 2032 (%)
  • 7.1.2. Polymer-based
  • 7.1.3. Non-polymer Based

8. Long-Acting Drug Delivery Technologies and Services Market - By Dosage Form

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
  • 8.1.2. Long Acting Injectables
  • 8.1.3. Long Acting Implantable
  • 8.1.4. Long-acting Oral
  • 8.1.5. Others

9. Long-Acting Drug Delivery Technologies and Services Market - By End User

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
  • 9.1.2. Pharmaceutical & Biotech Companies
  • 9.1.3. Research & Development
  • 9.1.4. Others

10. Long-Acting Drug Delivery Technologies and Services Market- By Geography

• 10.1. Introduction
  • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 10.2. North America
  • 10.2.1. Overview
  • 10.2.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in North America
  • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4. North America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.7. U.S.
    • 10.2.7.1. Overview
    • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3. U.S. Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.2.8. Canada
    • 10.2.8.1. Overview
    • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3. Canada Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.3. Europe
  • 10.3.1. Overview
  • 10.3.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Europe
  • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4. Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.7. Germany
    • 10.3.7.1. Overview
    • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3. Germany Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.8. Italy
    • 10.3.8.1. Overview
    • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3. Italy Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.9. United Kingdom
    • 10.3.9.1. Overview
    • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3. United Kingdom Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.10. France
    • 10.3.10.1. Overview
    • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3. France Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.11. Russia
    • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2. Russia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.12. Netherlands
    • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2. Netherlands Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.13. Sweden
    • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2. Sweden Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.14. Poland
    • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2. Poland Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3.15. Rest of Europe
    • 10.3.15.1. Overview
    • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.4. Asia Pacific (APAC)
  • 10.4.1. Overview
  • 10.4.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Asia Pacific
  • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4. Asia Pacific Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.7. India
    • 10.4.7.1. Overview
    • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3. India Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.8. China
    • 10.4.8.1. Overview
    • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3. China Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.9. Japan
    • 10.4.9.1. Overview
    • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3. Japan Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.10. South Korea
    • 10.4.10.1. Overview
    • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3. South Korea Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.11. Australia
    • 10.4.11.1. Overview
    • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3. Australia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.12. Thailand
    • 10.4.12.1. Overview
    • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3. Thailand Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.13. Indonesia
    • 10.4.13.1. Overview
    • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3. Indonesia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.14. Philippines
    • 10.4.14.1. Overview
    • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3. Philippines Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4.15. Rest of APAC
    • 10.4.15.1. Overview
    • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.5. Latin America
  • 10.5.1. Overview
  • 10.5.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Latin America
  • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4. Latin America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.7. Brazil
    • 10.5.7.1. Overview
    • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3. Brazil Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.8. Mexico
    • 10.5.8.1. Overview
    • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3. Mexico Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.9. Argentina
    • 10.5.9.1. Overview
    • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3. Argentina Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.10. Colombia
    • 10.5.10.1. Overview
    • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3. Colombia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5.11. Rest of LATAM
    • 10.5.11.1. Overview
    • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 10.6. Middle East and Africa
  • 10.6.1. Overview
  • 10.6.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Middle East and Africa
  • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4. Middle East and Africa Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
  • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
  • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.7. Saudi Arabia
    • 10.6.7.1. Overview
    • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.8. United Arab Emirates
    • 10.6.8.1. Overview
    • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.9. Israel
    • 10.6.9.1. Overview
    • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3. Israel Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.10. Turkey
    • 10.6.10.1. Overview
    • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3. Turkey Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.11. Algeria
    • 10.6.11.1. Overview
    • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3. Algeria Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.12. Egypt
    • 10.6.12.1. Overview
    • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3. Egypt Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6.13. Rest of MEA
    • 10.6.13.1. Overview
    • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Long-Acting Drug Delivery Technologies and Services Industry

• 11.1. Competitive Dashboard
• 11.2. Company Profiles
  • 11.2.1. Pfizer Inc.
  • 11.2.2. Roche Holding AG
  • 11.2.3. Novartis International AG
  • 11.2.4. Johnson & Johnson
  • 11.2.5. Boehringer Ingelheim
  • 11.2.6. Bristol-Myers Squibb
  • 11.2.7. Viatris Inc.
  • 11.2.8. ALZA Corporation
  • 11.2.9. Eli Lilly and Company
  • 11.2.10. Merck & Co., Inc.
  • 11.2.11. Sanofi S.A.
  • 11.2.12. AbbVie Inc.
  • 11.2.13. Gilead Sciences, Inc.
  • 11.2.14. GlaxoSmithKline plc
  • 11.2.15. AstraZeneca plc
  • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

• 13.1. Research Methodology
• 13.2. References
• 13.3. Abbreviations
• 13.4. Disclaimer
• 13.5. Contact Us